Comparison between IFN induction, induction plus Ribavirin and IFN plus Ribavirin combination therapy in naive patients with chronic hepatitis C related to genotype 1

被引：2
|
作者：
Bellobuono, A [1 ]
Tempini, S [1 ]
Idéo, GM [1 ]
Grimoldi, D [1 ]
Brasca, P [1 ]
Idéo, G [1 ]
机构：
[1] S Giuseppe Hosp, Ctr Liver Dis, Milan, Italy
来源：
JOURNAL OF HEPATOLOGY | 2000年 / 32卷
关键词：
D O I：
10.1016/S0168-8278(00)80755-2
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：110 / 110
页数：1
相关论文
共 50 条
  • [1] Comparison between IFN induction therapy, IFN induction plus ribavirin and IFN plus ribavirin standard combination therapy in naive patients with chronic hepatitis C related to genotype 1.
    Bellocuono, AAB
    Tempini, SST
    Mondazzi, LLM
    Ideo, GMGM
    Brasca, PPB
    Bellobuono, AAB
    Ideo, GGI
    HEPATOLOGY, 2000, 32 (04) : 366A - 366A
  • [2] Comparison between IFN induction therapy, IFN induction plus ribavirin and IFN plus ribavirin standard combination therapy in naive patients with chronic hepatitis C related to genotype 1:: Final report
    Bellobuono, A
    Tempini, S
    Cattaneo, C
    Grimoldi, D
    Bellobuono, A
    Di Berardino, F
    Idéo, GM
    Idéo, G
    JOURNAL OF HEPATOLOGY, 2001, 34 : 148 - 148
  • [3] Early response to IFN induction therapy, induction plus Ribavirin and IFN plus Ribavirin combination therapy in naive patients with chronic hepatitis C related to genotype 1.
    Bellobuono, AA
    Tempini, SS
    Ideo, GMG
    Brasca, PP
    Ideo, GG
    GASTROENTEROLOGY, 2000, 118 (04) : A1425 - A1425
  • [4] Combination therapy in naive patients with chronic hepatitis C related to genotype 1: Comparison between IFN plus Ribavirin and IFN plus Amantadine and between amantadine and ribavirin addition after 3 months in still viremic patients.
    Bellobuono, A
    Del Poggio, P
    Jamoletti, C
    Finazzi, R
    Rafaele-Milano, S
    Covini, G
    Milazzo, L
    Magni, C
    Milella, AM
    Paris, B
    Bozzetti, F
    Bellobuono, A
    Ideo, G
    HEPATOLOGY, 2002, 36 (04) : 573A - 573A
  • [5] Interferon (IFN) induction therapy in combination with ribavirin in chronic hepatitis C
    Ferenci, P
    Brunner, H
    Vogel, W
    Gschwantler, M
    Datz, C
    Hackl, F
    Steindl-Munda, P
    Hofer, H
    JOURNAL OF HEPATOLOGY, 2000, 32 : 38 - 38
  • [6] IFN plus ribavirin in HIV plus patients with chronic hepatitis C
    Pérez-Olmeda, M
    Gónzalez, J
    Garcia-Samaniego, J
    Arribas, J
    Peña, J
    Soriano, V
    JOURNAL OF HEPATOLOGY, 2000, 32 : 114 - 114
  • [7] Hepatitis C virus dynamics during induction with high PEG-IFN doses and ribavirin compared with low PEG-IFN doses plus ribavirin in naive patients with chronic hepatitis C, genotype 1
    Sánchez-Avila, JE
    Buti, M
    Lurie, Y
    Martell, M
    Esteban, R
    Guardia, J
    JOURNAL OF HEPATOLOGY, 2001, 34 : 5 - 5
  • [8] IFN plus ribavirin versus IFN plus amantadine in naive patients with chronic hepatitis C (Genotype 1) and amantadine versus ribavirin addition after 3 months in still viremic patients
    Bellobuono, A
    Finazzi, R
    Covini, G
    Milazzo, L
    Magni, C
    Milella, AM
    Janoletti, C
    Bozzetti, F
    Bellobuono, A
    Idéo, G
    GASTROENTEROLOGY, 2002, 123 (01) : 75 - 75
  • [9] Combination of interferon (IFN) induction therapy and ribavirin in chronic hepatitis C.
    Ferenci, P
    Brunner, H
    Vogel, W
    Gschwantler, M
    Datz, C
    Hackl, F
    Steindl-Munda, PE
    Hofer, H
    Mueller, C
    Mueller, C
    GASTROENTEROLOGY, 2000, 118 (04) : A961 - A961
  • [10] Oxidative stress and IFN plus ribavirin combination therapy in patients with chronic hepatitis C.
    Morisco, F
    Verde, V
    Fogliano, V
    Ritieni, A
    Iasevoli, P
    Tuccillo, C
    De Luise, G
    Caporaso, N
    GASTROENTEROLOGY, 2000, 118 (04) : A1471 - A1471
12345